No abstract available
MeSH terms
-
Alcohol Drinking / adverse effects
-
Antiviral Agents / therapeutic use*
-
Disease Progression
-
Drug Resistance, Multiple, Viral*
-
Drug Therapy, Combination
-
Hepatitis C, Chronic / complications
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / metabolism
-
Hepatitis C, Chronic / pathology
-
Hepatitis C, Chronic / therapy
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use*
-
Iron / metabolism*
-
Iron Overload / metabolism
-
Iron Overload / pathology
-
Iron Overload / therapy
-
Iron Overload / virology*
-
Liver / metabolism*
-
Liver / pathology
-
Liver / virology
-
Phlebotomy
-
Platelet Count
-
Recombinant Proteins
-
Ribavirin / therapeutic use*
-
Risk Factors
-
Severity of Illness Index
-
Sex Factors
-
Transaminases / blood
-
Treatment Failure
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Ribavirin
-
Iron
-
Transaminases